REG-BARCLAYS PLC Form 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Form 8.3 - STERIS CORPORATION
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the Code)
1. KEY INFORMATION
| (a) | Full name of discloser: | Barclays PLC. | |||
| (b) | Owner or controller of interest and short | ||||
| positions disclosed, if different from 1(a): | |||||
| (c) | Name of offeror/offeree in relation to whose | STERIS CORPORATION | |||
| relevant securities this form relates: | |||||
| (d) | If an exempt fund manager connected with an | ||||
| offeror/offeree, state this and specify identity of | |||||
| offeror/offeree: | |||||
| (e) | Date position held/dealing undertaken: | 21 October 2015 | |||
| (f) | In addition to the company in 1(c) above, is the discloser making | YES: | |||
| disclosures in respect of any other party to the offer? | SYNERGY HEALTH PLC |
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
| Class of relevant security: | ORD | ||||||||||
| Interests | Short Positions | ||||||||||
| Number | (%) | Number | (%) | ||||||||
| (1) | Relevant securities owned | ||||||||||
| and/or controlled: | 3,011 | 0.01% | 287,512 | 0.48% | |||||||
| (2) | Cash-settled derivatives: | ||||||||||
| 284,112 | 0.47% | 0 | 0.00% | ||||||||
| (3) | Stock-settled derivatives (including options) | ||||||||||
| and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||||||
| (4) | |||||||||||
| TOTAL: | 287,123 | 0.48% | 287,512 | 0.48% | |||||||
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form8 (Open Positions).
(b) Rights to subscribe for new securities (including directors and other employee options)
| Class of relevant security in relation to which subscription right exists: | |
| Details, including nature of the rights concerned and relevant percentages: |
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
| Class of relevant | Purchase/sale | Number of | Price per unit | ||||
| security | securities | ||||||
| ORD | Purchase | 7 | 68.4100 USD | ||||
| ORD | Purchase | 10 | 68.7100 USD | ||||
| ORD | Purchase | 24 | 68.9000 USD | ||||
| ORD | Purchase | 76 | 68.6709 USD | ||||
| ORD | Purchase | 76 | 68.6708 USD | ||||
| ORD | Purchase | 89 | 68.7305 USD | ||||
| ORD | Purchase | 100 | 68.8500 USD | ||||
| ORD | Purchase | 353 | 68.8153 USD | ||||
| ORD | Purchase | 478 | 68.8156 USD | ||||
| ORD | Purchase | 500 | 68.6368 USD | ||||
| ORD | Purchase | 717 | 68.7207 USD | ||||
| ORD | Purchase | 1,400 | 68.5997 USD | ||||
| ORD | Purchase | 1,400 | 68.4874 USD | ||||
| ORD | Purchase | 1,560 | 68.7878 USD | ||||
| ORD | Purchase | 2,650 | 68.7198 USD | ||||
| ORD | Purchase | 3,500 | 68.6772 USD | ||||
| ORD | Purchase | 3,706 | 68.6707 USD | ||||
| ORD | Purchase | 4,349 | 68.6573 USD | ||||
| ORD | Purchase | 9,000 | 68.6588 USD | ||||
| ORD | Purchase | 11,700 | 68.6924 USD | ||||
| ORD | Sale | 10 | 68.7100 USD | ||||
| ORD | Sale | 10 | 68.6800 USD | ||||
| ORD | Sale | 10 | 68.6200 USD | ||||
| ORD | Sale | 100 | 68.6500 USD | ||||
| ORD | Sale | 100 | 68.7400 USD | ||||
| ORD | Sale | 100 | 68.7800 USD | ||||
| ORD | Sale | 100 | 68.3100 USD | ||||
| ORD | Sale | 100 | 68.8600 USD | ||||
| ORD | Sale | 100 | 68.6400 USD | ||||
| ORD | Sale | 147 | 68.6403 USD | ||||
| ORD | Sale | 149 | 68.6994 USD | ||||
| ORD | Sale | 153 | 68.8454 USD | ||||
| ORD | Sale | 190 | 68.5466 USD | ||||
| ORD | Sale | 200 | 68.8000 USD | ||||
| ORD | Sale | 200 | 68.7500 USD | ||||
| ORD | Sale | 233 | 68.5369 USD | ||||
| ORD | Sale | 450 | 68.7722 USD | ||||
| ORD | Sale | 500 | 68.6100 USD | ||||
| ORD | Sale | 500 | 68.5858 USD | ||||
| ORD | Sale | 567 | 68.8076 USD | ||||
| ORD | Sale | 600 | 68.6866 USD | ||||
| ORD | Sale | 600 | 68.6833 USD | ||||
| ORD | Sale | 600 | 68.6183 USD | ||||
| ORD | Sale | 600 | 68.2903 USD | ||||
| ORD | Sale | 600 | 68.7666 USD | ||||
| ORD | Sale | 700 | 68.6362 USD | ||||
| ORD | Sale | 800 | 68.6887 USD | ||||
| ORD | Sale | 900 | 68.6127 USD | ||||
| ORD | Sale | 1,300 | 68.6359 USD | ||||
| ORD | Sale | 2,500 | 68.7508 USD | ||||
| ORD | Sale | 3,208 | 68.7819 USD | ||||
| ORD | Sale | 3,400 | 68.6488 USD | ||||
| ORD | Sale | 3,618 | 68.6709 USD | ||||
| ORD | Sale | 3,850 | 68.6708 USD | ||||
| ORD | Sale | 6,300 | 68.6759 USD | ||||
| ORD | Sale | 8,300 | 68.6607 USD |
(b) Cash-settled derivative transactions
| Class of relevant security | Product description e.g. CFD | Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
| Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit | Type e.g. American, European etc. | Expiry date | Option money paid/ received per unit |
(ii) Exercise
| Class of relevant security | Product description e.g. call option | Exercising/ exercised against | Number of securities | Exercise price per unit |
(d) Other dealings (including subscribing for new securities)
| Class of relevant security | Nature of dealing e.g. subscription, conversion | Details | Price per unit (if applicable) |
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
| Details of any indemnity or option arrangement, or any agreement or understanding, |
| formal or informal, relating to relevant securities which may be an inducement to deal |
| or refrain from dealing entered into by the person making the disclosure and any party |
| to the offer or any person acting in concert with a party to the offer: |
| NONE |
(b) Agreements, arrangements or understandings relating to options or derivatives
| Details of any agreement, arrangement or understanding, formal or informal, between |
| the person making the disclosure and any other person relating to: |
| (i) the voting rights of any relevant securities under any option; or |
| (ii) the voting rights of future acquisition or disposal of any relevant securities to which |
| any derivative is referenced: |
| NONE |
(c) Attachments
| Is a Supplemental Form 8 (Open Positions) attached? | NO | |
| Date of disclosure: | 22 Oct 2015 | |
| Contact name: | Jay Supaya | |
| Telephone number: | 020 7773 0635 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151022006000/en/
BARCLAYS PLC
Recent news on Steris
See all newsREG - Travelex Financing - Update on debt restructuring
AnnouncementREG - Synergy Health Steris Corp. - Scheme Effective <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - State Street Global Steris Corp. Synergy Health - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - Legal&Gen Inv Mgmnt Synergy Health Steris Corp. - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG-BARCLAYS PLC FORM 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Announcement